Stockholders' Equity (Tables)

9 Months Ended

Mar. 31, 2017

Schedule of stock-based compensation expense recorded in the condensed consolidated statements of operations

The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

	Three Months Ended March 31,						Nine Months Ended March 31,
	2016			2017			2016			2017
Cost of goods sold	$	302		$	417		$	899		$	1,116
Selling, general and administrative	4,456			5,627			12,475			15,909
Research and development	70			159			208			335
Restructuring	—			—			—			2,902

Stock-based compensation expense before taxes	$	4,828		$	6,203		$	13,582		$	20,262
Less: related income tax benefit	(1,850		)	(2,378		)	(5,184		)	(7,828		)

Stock-based compensation expense, net of estimated taxes	$	2,978		$	3,825		$	8,398		$	12,434

Summary of stock option activity

	Number of Options		Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2016	934,112		$	28.67
Granted	17,344		$	73.69
Exercised	(159,278	)	$	24.88
Expired or forfeited	(3,725	)	$	68.91

Outstanding at March 31, 2017	788,453		$	30.24	3.6 years	$	33,775

Exercisable at March 31, 2017	739,020		$	27.44	3.2 years	$	33,678

Summary of restricted stock award and RSU award activity

	Shares		Weighted- Average Fair Value
Nonvested at June 30, 2016	530,498		$	67.94
Granted	377,610		64.50
Vested	(294,893	)	68.05
Net replacement RSUs (1)	24,606		67.76
Forfeited	(19,065	)	68.24

Nonvested at March 31, 2017	618,756		$	65.77

(1)

Pursuant to the acquisition of AS&E, the Company assumed unvested RSUs originally granted by AS&E and converted them into RSUs for the Company’s common stock.